Investor News
ISO13485 certification for medical devices
Intelligent Ultrasound Group plc (AIM: MED) the ultrasound artificial intelligence (AI) software and simulation company, announces it has formally received ISO13485:2016 certification for its Quality Management System following review by the certification body LRQA. ISO13485:2016 is the internationally recognised quality standard to ensure the consistent design, development, production, installation and sale of medical devices that are safe for their intended purposes.
Director/PDMR shareholding
Intelligent Ultrasound Group plc (AIM: MED), the ultrasound artificial intelligence (AI) software and simulation company, announces the following director share transactions. The Company announces that Ian Whittaker, a Person Discharging Managerial Responsibilities of the Company ("PDMR"), transferred 374,982 Ordinary Shares in the Company for nil consideration on the 4th March 2020 to a nominee account of which he is the beneficial owner. Following this transaction, Ian Whittaker’s interest and that of his persons closely associated in Ordinary Shares remains unchanged at 374,982 Ordinary Shares of 1p representing 0.17% of the total issued share capital of the Company.
Notice of 2019 results
Intelligent Ultrasound Group plc (LSE: MED), the ultrasound artificial intelligence (AI) software and simulation company, announces it will issue its final results for the year ended 31 December 2019 on Thursday, 26 March 2020. The Company will host a briefing for analysts at the offices of Walbrook PR, 4 Lombard Street, London EC3V 9HD at 9.30am on Thursday, 26 March. If you would like to register to attend the analyst briefing or require further information, please contact Walbrook PR on 020 7933 8780 or email intelligentultrasound@walbrookpr.com.
Minister visit
Intelligent Ultrasound Group plc (AIM: MED) announces that the Chancellor of the Duchy of Lancaster, The Rt Hon Michael Gove MP and the Secretary of State for Wales, The Rt Hon Simon Hart MP, visited the Group’s head office to experience first hand the advances that the Group’s Clinical Artificial Intelligence Division has made with its real-time AI image guidance software, AnatomyGuide.
Growth & innovation forum 2020
Intelligent Ultrasound Group plc (AIM: MED) announces it will be exhibiting at the Growth & Innovation Forum 2020 on Tuesday 11 February at the Business Design Centre, London.
Trading update
Intelligent Ultrasound Group plc (AIM: MED), the ultrasound artificial intelligence (AI) software and simulation company, announces that Group revenue for the year to 31 December 2019, which is currently generated entirely by the Group’s Simulation Division, is expected to grow by around 10% from the £5.3m achieved in 2018 to between £5.7m and £5.9m. The Group is pleased that the Division continued to show year on year growth and the important agreement signed with FUJIFILM SonoSite Inc. in the second half of the year, will help increase future sales in the Division’s point-of-care ultrasound (POCUS) training market...
Directorate changes
Intelligent Ultrasound Group (AIM: MED), the intelligent ultrasound software and simulation company, is pleased to announce that Helen Jones is to be appointed as Group Finance Director and member of the Board of Directors effective from 1 January 2020. Ms. Jones will replace Wilson Jennings who has decided to retire from full-time employment in the New Year and will therefore be stepping down from the Board of the Company at that time.
Update on contingent liability
Intelligent Ultrasound Group (AIM: MED), the intelligent ultrasound software and simulation company, is pleased to announce that HMRC has informed the Group that it will not be seeking repayment of R&D tax credits paid to its subsidiary, Intelligent Ultrasound Limited (“IUL”), for the periods ended 14 June 2013 through to 30 September 2016.
Intelligent Ultrasound enters into an agreement with Fujifilm Sonosite, Inc. to develop clinician training
Intelligent Ultrasound Group (AIM: MED), the intelligent ultrasound software and simulation company, announces that FUJIFILM SonoSite, Inc., specialists in developing cutting-edge, point-of-care ultrasound solutions, and part of the greater Fujifilm Healthcare portfolio, has entered into an agreement with the Group allowing the companies to deliver a training solution to the point-of-care ultrasound (POCUS) market. The agreement includes Intelligent Ultrasound Group’s BodyWorks Eve POCUS training solution and the HeartWorks transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) simulator training platforms that can be used to accelerate training for all Fujifilm SonoSite’s POCUS systems.
Ultrasound AI database exceeds four million images
Intelligent Ultrasound (AIM: MED), the intelligent ultrasound software and simulation company, announces that its database used in the development of its artificial intelligence (“AI”) products now exceeds four million ultrasound images.